Research · 2026-07-12
Dermatologists Formally Recognize Kratom-Induced Skin Discoloration as Distinct Clinical Pattern
Source: Journal of Cutaneous Pathology
Why it matters
A formal review now establishes kratom-induced skin hyperpigmentation as an identifiable clinical entity that dermatologists and pathologists should add to their differential diagnoses. As kratom use expands nationally and regulatory scrutiny intensifies, clinicians will increasingly encounter patients with this condition — and most still do not recognize it.
The big picture
Multiple case reports published since 2022 document a pattern of photodistributed blue-gray or brown skin discoloration in chronic kratom users. The July 2026 review in the Journal of Cutaneous Pathology synthesizes this growing body of literature, describing characteristic histopathological findings and clinical presentations. Several prior cases were initially misdiagnosed as melasma, heavy metal deposition, or post-inflammatory changes before detailed histories revealed kratom use.
Key findings
- Photodistributed blue-gray or brown skin discoloration appears to be a reproducible side effect of chronic kratom use
- Biopsy findings show pigment-laden macrophages in the superficial dermis with melanin-like granules and a mild lymphohistiocytic infiltrate
- SEM-EDXA analysis identified sulfur-containing material consistent with phaeomelanin or drug-metabolite melanin-like complexes
- The condition can be misdiagnosed as melasma or heavy metal pigmentation without a thorough supplement and herbal use history
- Prior cases resolved or improved after kratom discontinuation; picosecond laser therapy has shown early promise for treatment
What they say
This case expands the clinicopathologic understanding of kratom-associated dermatoses and illustrates the utility of SEM-EDXA in identifying exogenous or drug-induced pigmentation. — Pei et al., Journal of Cutaneous Pathology, 2026
Bottom line
Kratom-induced skin hyperpigmentation is now formally recognized as an emerging dermatosis, which means every clinician seeing unexplained pigment changes should ask patients directly about herbal supplement use.